SCHEMBL1028839

SCHEMBL1028839

Nc1ncc(-c2ccc(N3CCOCC3)cc2)c(C2CCCCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.46
BMPR1B O00238 1/20 0.45
BMPR1A P36894 1/20 0.45
TGFBR1 P36897 1/20 0.45
ACVRL1 P37023 1/20 0.45
ACVR1 Q04771 1/20 0.45
PIK3CA P42336 7/20 0.45
AKT1 P31749 2/20 0.45
MTOR P42345 4/20 0.44
PIK3R1 P27986 2/20 0.44
CFTR P13569 1/20 0.44
ALOX5 P09917 2/20 0.43
GRIA1 P42261 1/20 0.43
AXL P30530 1/20 0.43
FLT3 P36888 1/20 0.43
TYRO3 Q06418 1/20 0.43
MERTK Q12866 1/20 0.43
CDK1 P06493 1/20 0.42
CDK2 P24941 1/20 0.42
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2558872 0.80 DHFR (0.60) DHFRPIK3CAMTORPIK3R1CDK1
SCHEMBL14694265 0.73 DHFR (0.58) DHFR
SCHEMBL28066917 0.73 TNK2 (0.58)
SCHEMBL28070394 0.72 TTK (0.52) DHFRPIK3CAMTORPIK3R1CDK1
SCHEMBL7712422 0.72 STK4 (0.54) DHFRPIK3CAAKT1MTORPIK3R1
SCHEMBL7712374 0.72 PIK3CA (0.48) DHFRPIK3CAMTORPIK3R1
SCHEMBL7714561 0.72 KDM4E (0.56) DHFRPIK3CAMTORPIK3R1ADK
SCHEMBL1033888 0.72 GABBR2 (0.51) DHFRCDK2
SCHEMBL7708544 0.71 NOS1 (0.58) DHFRPIK3CAMTORPIK3R1
SCHEMBL4466816 0.68 CDK1 (0.66) PIK3CAPIK3R1CDK1CDK2ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010068863-A2 PYRIMIDINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-06-17 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010068863-A2 PYRIMIDINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-06-17 WO disclosed